Eli Lilly has filed lawsuits against medical spas and online vendors for allegedly selling unauthorized versions of tirzepatide, the active ingredient in its weight-loss medication, Zepbound. This action comes despite the recent resolution of the FDA-declared tirzepatide injection shortage. Eli Lilly argues that these vendors are offering counterfeit products without FDA approval and are engaging in misleading advertising practices.
Police in Delhi have arrested a Syrian national and three other Indian nationals for allegedly manufacturing and supplying counterfeit cancer and diabetes medicines to international markets. The Syrian national, identified as Monir Ahmad, was found to be a key supplier of fake medicines to Turkey, Egypt, and India. The other accused have been identified as Naveen Arya, Saurabh Garg, and Karan Khaneja.
